# RYALTRIS
> **NDA211746** · New Drug Application · Sponsor: GLENMARK SPECLT · Approved 2022-01-13
## Drug
- **FDA Application Number:** NDA211746
- **Application type:** New Drug Application
- **Brand name:** RYALTRIS
- **Generic name:** OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE
- **Active ingredients:** MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
- **Dosage form:** SPRAY, METERED
- **Route:** NASAL
- **Marketing status:** Prescription
- **Sponsor:** GLENMARK SPECLT
- **Manufacturer:** HIKMA SPECIALTY USA INC.
- **First approval:** 2022-01-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211746)
---
*AI Analytics · CC0 1.0*